69 related articles for article (PubMed ID: 7459551)
21. [Combined treatment of non-small cell carcinoma of the lung with radiotherapy and moderate whole-body hyperthermia (author's transl)].
Hinkelbein W; Neumann H; Engelhardt R; Wannenmacher M
Strahlentherapie; 1981 May; 157(5):301-4. PubMed ID: 7245275
[TBL] [Abstract][Full Text] [Related]
22. [Clinical experience with different fractionation rhythm and single doses].
Lessel A; Eichhorn HJ
Radiobiol Radiother (Berl); 1972; 13(1):9-13. PubMed ID: 5035447
[No Abstract] [Full Text] [Related]
23. [Roentgenologic studies on frequency and time of onset of radiation-induced pneumonitis and fibrosis of lung parenchyma following in radiation of bronchial carcinoma. Comparison of different doses, rhythm of fractionation and size of radiated lung volumina].
Mateev B; Eichhorn HJ; Welker K
Strahlentherapie; 1971 Jul; 142(1):1-12. PubMed ID: 5116418
[No Abstract] [Full Text] [Related]
24. Cure of EMT-6 tumors by X rays or neutrons: effect of mixed-fractionation schemes.
Rasey JS; Carpenter RE; Nelson NJ; Parker RG
Radiology; 1977 Apr; 123(1):207-12. PubMed ID: 403569
[TBL] [Abstract][Full Text] [Related]
25. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
[TBL] [Abstract][Full Text] [Related]
26. Remarks about fractionation schemes.
Wideröe R
Strahlentherapie; 1979 Oct; 155(10):666-72. PubMed ID: 494338
[TBL] [Abstract][Full Text] [Related]
27. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
Koshy M; Malik R; Weichselbaum RR; Sher DJ
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):344-50. PubMed ID: 25636759
[TBL] [Abstract][Full Text] [Related]
28. [Effect of tissue inhomogeneities on planning irradiation. I. The effect of lung tissue on planning the irradiation of bronchial cancers with 60Co].
Welker K; Eichhorn HJ
Radiobiol Radiother (Berl); 1980; 21(3):309-21. PubMed ID: 7455013
[No Abstract] [Full Text] [Related]
29. Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.
Schenken LL; Poulakos L; Hagemann RF
Br J Cancer; 1975 Feb; 31(2):228-36. PubMed ID: 809050
[TBL] [Abstract][Full Text] [Related]
30. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
31. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
[TBL] [Abstract][Full Text] [Related]
32. [Dose fractionation in distance radiotherapy of malignant neoplasms].
Kozlov AP; Akimov AA
Vopr Onkol; 1983; 29(11):105-16. PubMed ID: 6359680
[No Abstract] [Full Text] [Related]
33. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
34. [Biomedical use and dosimetry of pions of the sin 590 MeV isochrone cyclotrone. VII. Radiation therapy using negative pions (author's transl)].
Wideröe R
Rofo; 1976 Feb; 124(2):182-5. PubMed ID: 131072
[TBL] [Abstract][Full Text] [Related]
35. [The influence of fractionation on the survival of patients following primary irradiation of bronchial carcinomas (author's transl)].
Mayr B; Lieven H
Strahlentherapie; 1981 Apr; 157(4):214-6. PubMed ID: 7245261
[TBL] [Abstract][Full Text] [Related]
36. Prospective studies with the CRE formula of prolonged fractionation schedules.
Notter G; Turesson I
Radiology; 1976 Dec; 121(3 Pt. 1):709-15. PubMed ID: 981673
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
38. [Results of combined drug and radiotherapy in bronchial carcinoma].
Hering K; Seegelken K
Strahlentherapie; 1976 Jul; 152(1):5-8. PubMed ID: 951718
[TBL] [Abstract][Full Text] [Related]
39. [Radiation therapy of bronchial carcinoma].
Franke HD; Kunstmann HW
Internist (Berl); 1970 Sep; 11(9):334-43. PubMed ID: 4991422
[No Abstract] [Full Text] [Related]
40. [Taxol and simultaneous radiotherapy in stage IIIA and IIIB, locally advanced, non-small-cell bronchial carcinoma. Phase-I clinical trial].
Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Kettner H; Kober B; Zamboglou N
Strahlenther Onkol; 1996 May; 172 Suppl 1():9-15. PubMed ID: 8633271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
